# RT With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer

> **NCT00956007** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Radiation Therapy Oncology Group** · enrollment: 702 (actual)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **BIOLOGICAL:** cetuximab
- **RADIATION:** intensity-modulated radiation therapy

## Key facts

- **NCT ID:** NCT00956007
- **Lead sponsor:** Radiation Therapy Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2010-03-31
- **Primary completion:** 2023-09-05
- **Final completion:** 2029-08
- **Target enrollment:** 702 (ACTUAL)
- **Last updated:** 2026-01-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00956007

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00956007, "RT With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer". Retrieved via MORVS 2026-10-19 from https://api.morvs.ai/clinical/NCT00956007. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*